From promoting to inhibiting: diverse roles of helicases in HIV-1 Replication
© Lorgeoux et al.; licensee BioMed Central Ltd. 2012
Received: 5 December 2011
Accepted: 22 September 2012
Published: 28 September 2012
Helicases hydrolyze nucleotide triphosphates (NTPs) and use the energy to modify the structures of nucleic acids. They are key players in every cellular process involving RNA or DNA. Human immunodeficiency virus type 1 (HIV-1) does not encode a helicase, thus it has to exploit cellular helicases in order to efficiently replicate its RNA genome. Indeed, several helicases have been found to specifically associate with HIV-1 and promote viral replication. However, studies have also revealed a couple of helicases that inhibit HIV-1 replication; these findings suggest that HIV-1 can either benefit from the function of cellular helicases or become curtailed by these enzymes. In this review, we focus on what is known about how a specific helicase associates with HIV-1 and how a distinct step of HIV-1 replication is affected. Despite many helicases having demonstrated roles in HIV-1 replication and dozens of other helicase candidates awaiting to be tested, a deeper appreciation of their involvement in the HIV-1 life cycle is hindered by our limited knowledge at the enzymatic and molecular levels regarding how helicases shape the conformation and structure of viral RNA-protein complexes and how these conformational changes are translated into functional outcomes in the context of viral replication.
KeywordsHIV-1 helicase RNP
Human immunodeficiency virus type 1 (HIV-1) is a lentivirus. Replication of the HIV-1 RNA genome involves reverse transcription by viral reverse transcriptase, integration into cellular DNA by viral integrase, and transcription by cellular RNA polymerase II. HIV-1 RNA is subject to the regulation by viral proteins including Tat, Rev, and Gag that recognize specific viral RNA structures. Tat binds to the TAR (transactivation response) RNA that is located at the very 5′ end of the viral genome, and it further recruits cellular factors including the P-TEFb (positive transcription elongation factor b) complex to the HIV-1 promoter and enhances transcription . Rev recognizes the RRE (Rev response element) RNA that is located within the envelope protein-coding region, and it promotes the nuclear export of unspliced and partially spliced viral RNA via association with the CRM1 (chromosome region maintenance 1, also named exportin 1) nuclear export machinery . Gag recognizes the viral RNA packaging signals located at the 5′ untranslated region (5′UTR) and recruits two copies of full-length HIV-1 RNA into each virus particle . Recent studies have begun to reveal that a group of cellular proteins named helicases modulate HIV-1 replication through interacting with Tat, Rev and Gag proteins.
Helicases share conserved core structures and have diversified functions
Helicases are enzymes that hydrolyze NTPs (nucleotide triphosphates) and use the energy to unwind nucleic acid duplexes or to translocate along the nucleic acid strand . They are ubiquitously expressed and participate in almost every cellular event involving nucleic acids. Helicases are characterized by two RecA-like domains that exhibit ATP-binding as well as nucleic acid-binding properties. Among the conserved motifs that helicases carry are the Walker A and B boxes that bind and hydrolyze NTPs, as well as the “arginine fingers” that couple NTP hydrolysis with nucleic acid unwinding or translocating activities. On the basis of their conserved motifs and enzymatic properties, helicases are classified into six superfamilies (SF) . SFI and SFII have the most members, they function in a monomeric or a dimeric form. Many SF1 and SFII helicases contain the DExD/H motif . Members of SFIII to SFVI are of viral or bacterial origin and often form hexamers [10, 11]. Depending on whether they unwind RNA or DNA duplexes, helicases are also grouped as RNA helicases and DNA helicases. But this definition can become ambiguous for some helicases, such as RNA helicase A (RHA), that are able to unwind both RNA and DNA . An RNA helicase database is now available at http://www.rnahelicase.org.
The biochemical properties of helicases can be defined by four measurable parameters. These include, 1) translocation rate, which represents the number of bases translocate per second; 2) directionality of action either from 5′ to 3′ or from 3′ to 5′; 3) processivity which is characterized by the number of rounds of catalysis before a helicase falls off the substrate; and 4) step size which represents the number of base pairs translocated during each NTP hydrolysis event . Helicases differ considerably in their biochemical properties. For example, hexameric helicases often translocate long distance on DNA before falling off, whereas RNA helicases of the DEAD-box family unwind a short stretch of double-stranded RNA of no more than two helical turns. Even among DEAD-box helicases, they exhibit a wide array of activities . For example, the DEAD-box protein eIF4AIII, upon binding to ATP, shows RNA clamping activity and serves to recruit the core components of exon junction complex (EJC) . DDX21 (also named RH-II/GuA) acts as a strand annealer in an ATP-independent manner . These biochemical properties often determine the biological functions of helicases.
Helicases are also regulated by co-factors. For example, the translation initiation factor eIF4A alone exhibits low ATP-dependent helicase activity . Binding to eIF4B and eIF4H greatly enhances the ability of eIF4A to unwind RNA . In addition, a local activation of the yeast helicase Dbp5 by inositol hexakisphosphate 6 (InsP6) and Gle1 leads to the removal of mRNA export factor Mex67 when mRNA arrives at the cytoplasmic side of the nuclear pore complex (NPC) [18, 19]. Therefore, despite the conserved motifs and the similar folding that all helicase core domains share, each helicase is highly specific in its way to modify nucleic acid structures and regulate nucleic acid functions.
Helicases as the co-factors of HIV-1 Tat
WRN is a member of the RECQ helicase family that also consists of RECQL (RECQ protein-like), BLM (bloom syndrome), RECQ4/RTS (Rothmund-Thomson syndrome) and RECQ5. RECQ helicases harbor the DEAH motif and belong to SFII. They are capable of resolving complex DNA structures that often block DNA replication fork progression . In addition to its role in DNA recombination, WRN also promotes RNA polymerase II-dependent transcription, which is partially attributable to its ability to stimulate the DNA-unwinding activity of DNA topoisomerase I . In line with its role in transcription, WRN was recently shown to interact with HIV-1 Tat and promote HIV-1 LTR transactivation (Figure 2) . WRN and Tat are co-localized within the nuclei of HIV-1 infected cells. The purified recombinant GST-Tat is able to pull down the endogenous WRN. WRN appears to enhance HIV-1 gene expression by facilitating the recruitment of PCAF and P-TEFb to HIV-1 LTR . In support of this role of WRN, ectopic expression of wild type WRN in human lymphocytes increases HIV-1 p24(Gag) production and viral replication.
In addition to the WRN helicase, RHA has also been shown to promote TAR-dependent HIV-1 gene expression . RHA contains the DEIH Walker B motif, is a DEXH helicase. In addition to the helicase core domain, RHA has two double-stranded RNA-binding domains (dsRBDs) at its N-terminal region and the arginine- and glycine-rich (RGG) repeats at its C-terminal region (Figure 2) . These latter domains target RHA to its RNA substrates. HIV-1 TAR RNA has been shown binding to the N-terminal dsRBDs of RHA [21, 25]. This interaction allows RHA to affect a few steps of HIV-1 replication including transcription. Similar to WRN, RHA increases both basal activity from HIV-1 LTR and Tat transactivation (Figure 2) . It is unclear whether RHA directly interacts with Tat as WRN does. Interestingly, the dsRBD II and the RGG repeats of RHA directly interact with the N-terminal exonuclease domain of WRN, and stimulate its exonuclease activity . With such an interaction, RHA promotes the WRN-mediated degradation of D-loop DNA as well as the unwinding of Okazaki fragment-like hybrids [26, 27]. It is thus conceivable that these two helicases may act together to promote HIV-1 RNA synthesis (Figure 2).
The essential role of helicases in Rev-dependent RNA export
Human genes vs Yeast homologs
DDX3 is a DEAD-box protein (Figure 3A). Although DDX3 has been shown to interact with RNA transport factors TAP/NXF1 and REF/Aly, it does not appear to play a role in bulk mRNA export [32–34]. It is interesting to note that Ded1 (yeast DDX3 homolog) modulates translation by controlling the conformation of eIF4F-mRNA complex , suggesting a role of Ded1/DDX3 in translation. The function of DDX3 in RNA export was not recognized until DDX3 was found to participate in the Rev-dependent export of unspliced and partially spliced HIV-1 RNAs . Rev is co-immunoprecipitated with DDX3, but a direct interaction between the two proteins has not been experimentally demonstrated. Rather, the purified GST-CRM1 is able to pull down the in vitro translated DDX3. This direct interaction depends on the DDX3 fragment at amino acid positions 260 to 517 that does not include the NES (nuclear export signal) sequence, and is Ran-GTP independent (Figure 3A, 3C), which suggests that instead of a cargo, DDX3 acts as an effector in the CRM1-mediated nuclear export pathway.
In support of the important role of DDX3 in Rev-dependent HIV-1 RNA export, knockdown of DDX3 or expression of the dominant negative mutant of DDX3 significantly diminishes HIV-1 replication . Mutation of a unique fragment between the helicase motifs I and Ia diminishes the ability of DDX3 to bind to HIV-1 RNA and impairs HIV-1 replication . Interestingly, a ligand of this unique region reduces HIV-1 infection of HeLaP4 cells, suggesting the possibility of targeting this domain to abrogate the function of DDX3 in HIV-1 replication. It remains to be tested whether DDX3 is involved in CRM1-mediated export of cellular RNAs such as snRNA and rRNA, and to elucidate the molecular details regarding how DDX3 promotes RNA export.
In addition to DDX3, the RNA helicase DDX1 has also been reported to associate with Rev and promote the export of RRE-containing viral RNA (Figure 3A) . Purified DDX1 exhibits RNA-dependent ATPase activity. The DDX1 sequence from amino acids 189 to 333 directly interacts with the nuclear inhibitory signal (NIS) at amino acids 10 to 24 in Rev. Through this interaction, DDX1 promotes Rev oligomerization on the RRE RNA (Figure 3B, 3C) [39, 40]. This function of DDX1 is important because coordinated binding of multiple copies of Rev, rather than Rev monomer, to the RRE is required for initiating RNA export . In support of its role as a co-factor of Rev, the low DDX1 level in astrocytes results in a predominant cytoplasmic location of Rev, which partially accounts for the poor susceptibility of this cell type to HIV-1 infection . On the basis of these observations, we propose that DDX1 and DDX3 act sequentially in the Rev-dependent RNA export (Figure 3C). DDX1 first binds to Rev and promotes Rev oligomerization on the RRE RNA. Then the oligomerized Rev molecules, through presenting multiple copies of NES, recruit the CRM1/DDX3 complex that subsequently exports the RRE-containing HIV-1 RNA into the cytoplasm.
A recent proteomic study led to the finding of more helicases that associate with HIV-1 Rev . In addition to DDX1 and DDX3, these include DDX5, DDX17, DDX21, DHX36, DDX47 and RHA. Silencing DDX5, DDX17 or DDX21 significantly modulates the production of HIV-1 particles, suggesting a functional role of these helicases in HIV-1 replication. It remains to be further investigated how each of these helicases affects the function of Rev and whether they play redundant roles or are involved in distinct steps of Rev-mediated RNA export. Interestingly, these helicases were not reported to associate with Rev in a separate protoemic study that employed the affinity tagging purification and mass spectrometry methods to identify cellular factors that interact with each of the 18 HIV-1 proteins . This discrepancy may reflect the RNA-dependent nature of the Rev-helicase interaction.
Helicases in HIV-1 particles
Gag makes HIV-1 particles . In addition to viral RNA and viral proteins, a variety of cellular factors find their way into virus particles via direct or indirect interactions with Gag [46, 47]. Among the many cellular factors are two helicases, RHA and MOV10 (Moloney leukemia virus 10 homolog) [48–51]. These two helicases both affect HIV-1 reverse transcription but with opposite outcomes.
RHA interacts with Gag in an RNA-dependent manner . Knockdown of RHA in virus producer cells diminishes the infectivity of progeny HIV-1 particles, suggesting a functional role of the presence of RHA in the virions [25, 48]. This deficit in infectivity is caused at least in part by decreased viral reverse transcription [25, 48]. A further analysis of the viral RNA complex within the RHA-depleted virus particles reveals a reduced level of tRNALys.3 that is annealed onto the primer binding site (PBS) . This latter finding is verified by in vitro study showing that the purified recombinant wild type RHA, but not its helicase-null mutant K417R, assists Gag/NC in promoting the formation of tRNALys.3/viral RNA binary complex . Moreover, this binary viral RNA complex that is formed with the assistance of RHA exhibits higher efficiency in reverse transcription , which suggests that RHA not only promotes the annealing of tRNALys.3 onto viral RNA but also helps the viral RNA complex to adopt conformations in favor of the action of viral reverse transcriptase.
MOV10 may not act alone to inhibit HIV-1 reverse transcription. It is known that MOV10 binds to Ago2 and is a player in the microRNA pathway . This function allows MOV10 to control local protein translation at synapses and modulate synaptic plasticity . Ago2 was recently detected in HIV-1 particles . This latter finding raises the possibility that MOV10 and Ago2 may be packaged into virus particles as one complex and, together, modulate the function of viral RNA.
RHA enhances HIV-1 RNA translation
The role of RHA in HIV-1 replication goes beyond enhancing viral transcription and reverse transcription. RHA also increases HIV-1 RNA translation (Figure 5) . This function of RHA depends on its binding to the R/U5 sequence of HIV-1 RNA that has been named the post-transcriptional control element (PCE). The PCE exists in the 5′UTRs of different retroviruses, including spleen necrosis virus (SNV), Mason-Pfizer monkey virus (MPMV), human foamy virus (HFV), reticuloendotheliosis virus strain A (REV-A), human T-cell leukemia virus type 1 (HTLV-1), feline leukemia virus (FeLV), and bovine leukemia virus (BLV) . Studies show that RHA augments translation by promoting the association of PCE-containing RNA with polyribosomes . This translation mechanism may have a cellular origin, since the translation of cellular junD mRNA is stimulated by RHA in a 5′UTR-dependent manner .
RHA is not the only helicase that promotes the translation of mRNA having structured 5′UTR. DHX29 has been reported to facilitate the formation of the 48S translation initiation complex on the AUG codon of mRNAs such as neutrophil cytosolic factor 2 (NCF2) and CDC25 that harbor secondary structures at their 5′UTRs [62, 63]. These findings suggest that in addition to the RNA helicase eIF4A that functions as a conical translation initiation factor, the translation of specific mRNA may benefit from the action of other helicases .
RHA contributes to one of the several translation mechanisms that HIV-1 has harnessed to ensure efficient production of viral proteins. First, the activity of internal ribosome entry site (IRES) has been detected in the HIV-1 5′UTR and the Gag-coding region [64, 65], which allows translation to initiate in a cap-independent fashion. It has been noted that HIV-1 PCE and IRES are mapped to different sequences of the 5′UTR [25, 65], indicating that they represent distinct translation mechanisms. Second, the Rev/RRE-exported viral RNAs have a trimethylguanosine (TMG) cap at their 5′ ends as opposed to the 7-methylguanosine (m7G) at the 5′ end of most cellular mRNA . The TMG cap is synthesized by the PIMT enzyme (peroxisome proliferator-activated receptor-interacting protein with methyltransferases) that is recruited to HIV-1 RNA through binding to Rev. As a result, PIMT increases the translation of Rev-exported viral RNA. It is postulated that this mechanism ensures the production of optimal amounts of viral structural proteins at the late stage of HIV infection to produce virus particles. This finding also explains why Rev, besides its role in RNA export, also enhances translation [67, 68].
These different translation mechanisms contribute to HIV-1 protein production at different levels and under different conditions. RHA, through binding to R/U5 that is present on both spliced and unspliced HIV-1 RNAs, promotes the synthesis of all HIV-1 proteins, whereas the TMG cap, whose formation is Rev-dependent, increases the translation of viral structural proteins. In regard to HIV-1 IRES, its activity is cell cycle-dependent and responds to oxidative stress [65, 69, 70].
Upf1 associates with the 3′UTR of HIV-1 RNA
Upf1 is a key component of the NMD core machinery . As an SFI RNA helicase, Upf1 exhibits nucleic acid-dependent ATPase activity and 5′ to 3′ RNA unwinding activity . Using the RNA affinity purification technique and the mass spectrometry method, Hogg and Goff discovered that Upf1 associates with HIV-1 3′UTR and other model 3′UTRs . When the abundance of Upf1 association with a 3′UTR exceeds a certain threshold, the RNA is marked as a potential substrate for NMD. Frequent translation readthrough counters this mechanism by displacing Upf1 from the 3′UTR . Interestingly, rare translation readthrough also rescues the RNA from NMD without affecting the association of Upf1 with 3′UTR, which suggests a two-step model for Upf1 to sense 3′UTR and to potentiate decay. Since HIV-1 and other retroviruses use the frame shift mechanism to read through the stop codon of Gag in order to produce the Gag-Pol polyprotein, this translation mechanism may protect HIV-1 RNA from Upf1-mediated RNA decay. In support of this possible counter measure, it has been reported that Rous sarcoma virus (RSV) has the RSV stability element (RSE) that contains a frame shift pseudoknot and prevents the Upf1-dependent degradation of unspliced RSV RNA . However, the story of Upf1 and HIV-1 may be more complicated. One study shows that the knockdown of Upf1 in HeLa cells leads to decreased levels of both HIV-1 RNA and viral Gag protein and that this observation is independent of the role of Upf1 in NMD . This study concluded that HIV-1 has evolved to use Upf1 to stabilize viral RNA. Further studies are warranted to define how Upf1 modulates HIV-1 replication in HIV-1 natural target cells such as primary CD4+ T cells.
In addition to Upf1, HIV-1 RNA was recently shown being subject to ZAP (zinc finger antiviral protein)-mediated degradation (Figure 6) . ZAP was originally reported to inhibit murine leukemia virus (MLV) infection . Interestingly, ZAP causes the degradation of multiply spliced HIV-1 RNA while sparing the unspliced and singly spliced viral RNA [78, 79]. This degradation process can be initiated either by shortening the 3′ polyadenylation tail or by removing the 5′ cap. Two RNA helicases, DDX17 and DHX30, were found as co-factors of ZAP [76, 80, 81], which may function by remodeling the viral RNP and assisting the recruitment RNA degradation machinery. A similar role of RNA helicase in cellular RNA degradation has been reported for Mtr4 in yeast that bridges the TRAMP (Trf4/Air2/Mtr4 polyadenylation) complex to exosomes and remodels substrate RNA molecules [82, 83].
DDX24 and DHX30 modulate HIV-1 RNA packaging
Each HIV-1 particle packages two copies of unspliced viral RNA that are non-covalently linked via the RNA stem-loop structure SL1 that is defined as the dimerization initiation site (DIS) [2, 84, 85]. The NC domain of Gag is primarily responsible for recognizing the RNA packaging signals that comprise the SL1, SL2 and SL3 RNA structures at the 5′UTR [86, 87]. The nuclear magnetic resonance (NMR) structures of the 712-nt HIV-1 5′-leader RNA reveal a structure-based coordination of HIV-1 RNA packaging, dimerization and translation . In addition to these cis-acting viral RNA signals at the 5′UTR, the Rev/RRE system has also been shown to significantly augment HIV-1 RNA packaging . A direct involvement of helicases in HIV-1 RNA packaging has not been documented, although it is known that bacteriophages use helicases as motors to “thread” phage DNA into their capsids . Nonetheless, a couple of helicases have been implicated in modulating the genome packaging of some retroviruses including HIV-1. For example, DDX6 was reported to affect the viral genome packaging of foamy virus, a spumaretrovirus . Relocation of DDX6 from P bodies and stress granules to virus assembly sites at the perinuclear region was seen in cells infected with foamy virus. However, no interaction was detected between DDX6 and Gag, and DDX6 was not seen in the virus particles . As opposed to the reported role of DDX6 in foamy virus assembly, DDX6 binds to HIV-1 Gag and promotes Gag assembly, independent of viral RNA packaging . We previously observed that knockdown of the RNA helicase DDX24 diminishes HIV-1 RNA packaging . This effect was seen only for Rev/RRE-exported, not for CTE (constitutive transport element)-exported viral RNA, which likely results from the interaction of DDX24 with Rev. With its predominant location within the nucleolus, DDX24 may gain access to HIV-1 RNA through association with Rev and participates in viral RNA remodeling. The effect may then extend to the viral RNA packaging event that takes place within the cytoplasm. In contrast to the stimulatory effect of DDX24, another RNA helicase, DHX30, inhibits HIV-1 RNA packaging , which may be attributable to its accessory role in ZAP-mediated HIV-1 RNA degradation .
The putative role of helicases in HIV-1 DNA integration
Integration of HIV-1 DNA into cellular DNA is catalyzed by viral integrase in the context of pre-integration complex (PIC) [95, 96]. The PIC consists of the full-length HIV-1 DNA, integrase, viral and cellular factors that assist viral DNA integration. In addition to a number of cellular proteins such as BAF (barrier-to-autointegration factor), Gemin2, EED (embryonic ectoderm development), integrase interactor 1, and LEDGF/p75 (lens epithelium-derived growth factor), the helicase DDX19A was recently shown to likely associate with the PIC . Using the yeast two-hybrid method, Studamire and Goff screened for cellular proteins that interact with the integrase of Moloney murine leukemia virus (MoMLV) . The candidates include several helicases such as Ku70/XRCC6, DDX5 and DDX18. It would be interesting to test whether these helicases also associate with HIV-1 integrase and whether they play a functional role in HIV-1 DNA integration. It should be noted that no helicase has ever been shown experimentally to interact with HIV-1 integrase, therefore a direct role of helicase in HIV-1 DNA integration remains to be established.
Despite not being components of the PIC, helicases in the DNA repair machinery may participate in HIV-1 DNA integration in an indirect manner. For example, unintegrated HIV-1 DNA has been reported to be the substrate of the non-homologous DNA end joining (NHEJ) pathway . Knockdown of the Ku80 DNA helicase, a key player in NHEJ, reduces HIV-1 DNA integration and diminishes viral replication in human CEM4fx cells . In one study, 232 host DNA repair proteins were silenced using siRNA oligos and the effects on HIV-1 DNA integration were measured . The targeted proteins are involved in base excision repair (BER), nucleotide excision repair (NER), NHEJ, single strand break repair (SSBR), double strand break repair (DSB), mismatch repair (MMR), and homologous recombination (HR). The results revealed an important role of the BER pathway in HIV-1 DNA integration [100, 101]. Notably, knockdown of a few DNA repair helicases including ERCC3 and RECQL4 diminishes HIV-1 infection, suggesting their role in viral DNA integration .
Instead of assisting HIV-1 DNA integration, certain DNA repair machineries exert inhibitory effects. For example, NER-deficient cells that are mutated in the helicases XPB and XPD are more susceptible to transduction by HIV-based retroviral vectors owing to an increase in the integrated viral DNA [102, 103]. This suggests a role of these two DNA helicases, and likely via the underlying NER pathway, in defending cells against retroviral integration. In conclusion, no helicase has been reported to specifically interact with HIV-1 integrase and thereby modulate directly viral DNA integration. Evidence does suggest that some helicases become involved in HIV-1 DNA integration in the context of DNA repair pathways.
RIG-I is curtailed by viral protease for sensing HIV-1 RNA
A small family of DExD/H helicases including RIG-I (retinoic acid-inducible gene I), MDA-5 (melanoma differentiation associated protein-5) and LGP2 (laboratory of genetics and physiology 2) recognize viral RNA and trigger interferon production . Although transfecting the monomeric and dimeric HIV-1 RNA into cells triggers interferon production in a RIG-I-dependent manner, HIV-1 infection of monocyte-derived macrophages does not induce interferon response . This suggests that HIV-1 has a mechanism to evade the recognition by RIG-I. Indeed, further studies showed that HIV-1 protease removes RIG-I from the cytosol to an insoluble fraction, therefore inhibiting RIG-I-mediated antiviral signaling .
HIV-1 engages helicases to facilitate viral replication at different steps. This engagement is achieved by interacting with helicases via either viral RNA or viral proteins. For example, RHA binds to the R/U5 region of HIV-1 RNA and promotes viral gene expression and viral reverse transcription [21, 25, 48, 52]. DDX1 and DDX3 are associated with the Rev/RRE/CRM1 complex and regulate viral RNA export [3, 38, 40]. Also, WRN interacts with Tat and elevates HIV-1 gene expression . Recruiting these helicases to viral RNP complexes at different stages of viral replication reflects the need of HIV-1 to harness cellular helicases to overcome certain rate-limiting steps of viral RNA replication or to accomplish an activity that rarely occurs to cellular RNA such as reverse transcription. Opening the door to cellular helicases also exposes the virus to helicases that are deleterious to HIV-1 replication. One such example is MOV10 that finds its way into HIV-1 particles and impairs viral reverse transcription [49–51].
More cellular helicases than described herein may associate with HIV-1, given that a dozen of helicases have been reported in several genome-wide functional screens that were aimed at identifying cellular proteins that modulate HIV-1 infection. These include DDX10, DDX19, DDX33, DDX53, DDX50, DDX55, DDX60L, FBXO18, IGHMBP2, YTHDC2, HFM1, RECQL4, RUVBL2 [97, 106–108]. Furthermore, studies have also shown that HIV-1 infection alters the expression of a handful of cellular helicases [109, 110]. Last but not least, in a recent study aimed at comprehensively mapping the interactions between cellular factors and each of the HIV-1 18 proteins, DDX49 was reported to associate with Gag, DDX20 with Vpr, and RECQ1 with Pol . An important future task is to characterize the interactions of these candidate helicases with HIV-1 and to decipher their functions in HIV-1 infection.
How many helicases does HIV-1 really need? How many of these helicases play redundant roles in HIV-1 replication? In addition to these questions, we also lack a detailed knowledge at the molecular and enzymatic levels regarding how a helicase promotes or impedes a specific step of HIV-1 replication. It will be a challenging task to determine experimentally when and where a specific helicase becomes associated with HIV-1 RNPs, and it is also challenging to discern the structural and biochemical changes that a specific helicase can introduce into HIV-1 RNPs. Knowing these biochemical and enzymatic details will not only help to further elucidate the role of a helicase in HIV-1 RNA metabolism, but will also aid in the discovery of helicase inhibitors that may have the potential for treating HIV-1 infection .
We thank Dr. Lawrence Kleiman, Dr. Richard Sloan and Daniel Donahue for critical reading of the manuscript and useful suggestions. This work was supported by grants from the Canadian Institutes of Health Research.
Note: While this manuscript was under review, two reviews on the topic of cellular helicases and HIV-1 replication were published by Dr. Jeang’s and Dr. Mouland’s group [112, 113]. Readers are encouraged to read also these two timely review articles.
- Nekhai S, Jeang KT: Transcriptional and post-transcriptional regulation of HIV-1 gene expression: role of cellular factors for Tat and Rev. Future Microbiol. 2006, 1: 417-426. 10.2217/174609126.96.36.1997.PubMed
- Berkowitz R, Fisher J, Goff SP: RNA packaging. Curr Top Microbiol Immunol. 1996, 214: 177-218. 10.1007/978-3-642-80145-7_6.PubMed
- Yedavalli VS, Neuveut C, Chi YH, Kleiman L, Jeang KT: Requirement of DDX3 DEAD box RNA helicase for HIV-1 Rev-RRE export function. Cell. 2004, 119: 381-392. 10.1016/j.cell.2004.09.029.PubMed
- Jeang KT, Yedavalli V: Role of RNA helicases in HIV-1 replication. Nucleic Acids Res. 2006, 34: 4198-4205. 10.1093/nar/gkl398.PubMed CentralPubMed
- Ranji A, Boris-Lawrie K: RNA helicases: emerging roles in viral replication and the host innate response. RNA Biol. 2010, 7: 775-787. 10.4161/rna.7.6.14249.PubMed CentralPubMed
- Steimer L, Klostermeier D: RNA helicases in infection and disease. RNA Biol. 2012, 9: -Epub ahead of print
- Sharma A, Boris-Lawrie K: Determination of host RNA helicases activity in viral replication. Methods Enzymol. 2012, 511: 405-435.PubMed
- Singleton MR, Dillingham MS, Wigley DB: Structure and mechanism of helicases and nucleic acid translocases. Annu Rev Biochem. 2007, 76: 23-50. 10.1146/annurev.biochem.76.052305.115300.PubMed
- Linder P, Jankowsky E: From unwinding to clamping - the DEAD box RNA helicase family. Nat Rev Mol Cell Biol. 2011, 12: 505-516. 10.1038/nrm3154.PubMed
- Rabhi M, Tuma R, Boudvillain M: RNA remodeling by hexametric RNA helicases. RNA Biol. 2010, 7: 655-666. 10.4161/rna.7.6.13570.PubMed
- Patel SS, Picha KM: Structure and function of hexametric helicases. Annu Rev Biochem. 2000, 69: 651-697. 10.1146/annurev.biochem.69.1.651.PubMed
- Zhang S, Grosse F: Multiple functions of nuclear DNA helicase II (RNA helicase A) in nucleic acid metabolism. Acta Biochim Biophys Sin (Shanghai). 2004, 36: 177-183. 10.1093/abbs/36.3.177.
- Jankowsky A, Guenther UP, Jankowsky E: The RNA helicase database. Nucleic Acids Res. 2011, 39: D338-D341. 10.1093/nar/gkq1002.PubMed CentralPubMed
- Bono F, Gehring NH: Assembly, disassembly and recycling: the dynamics of exon junction complexes. RNA Biol. 2011, 8: 24-29. 10.4161/rna.8.1.13618.PubMed CentralPubMed
- Valdez BC: Structural domains involved in the RNA folding activity of RNA helicase II/Gu protein. Eur J Biochem. 2000, 267: 6395-6402. 10.1046/j.1432-1327.2000.01727.x.PubMed
- Parsyan A, Svitkin Y, Shahbazian D, Gkogkas C, Lasko P, Merrick WC, Sonenberg N: mRNA helicases: the tacticians of translational control. Nat Rev Mol Cell Biol. 2011, 12: 235-245. 10.1038/nrm3083.PubMed
- Rogers GW, Richter NJ, Lima WF, Merrick WC: Modulation of the helicase activity of eIF4A by eIF4B, eIF4H, and eIF4F. J Biol Chem. 2001, 276: 30914-30922. 10.1074/jbc.M100157200.PubMed
- Weirich CS, Erzberger JP, Flick JS, Berger JM, Thorner J, Weis K: Activation of the DExD/H-box protein Dbp5 by the nuclear-pore protein Gle1 and its coactivator InsP6 is required for mRNA export. Nat Cell Biol. 2006, 8: 668-676. 10.1038/ncb1424.PubMed
- Montpetit B, Thomsen ND, Helmke KJ, Seeliger MA, Berger JM, Weis K: A conserved mechanism of DEAD-box ATPase activation by nucleoporins and InsP6 in mRNA export. Nature. 2011, 472: 238-242. 10.1038/nature09862.PubMed CentralPubMed
- Sharma A, Awasthi S, Harrod CK, Matlock EF, Khan S, Xu L, Chan S, Yang H, Thammavaram CK, Rasor RA, et al: The Werner syndrome helicase is a cofactor for HIV-1 long terminal repeat transactivation and retroviral replication. J Biol Chem. 2007, 282: 12048-12057.PubMed
- Fujii R, Okamoto M, Aratani S, Oishi T, Ohshima T, Taira K, Baba M, Fukamizu A, Nakajima T: A Role of RNA Helicase A in cis-Acting Transactivation Response Element-mediated Transcriptional Regulation of Human Immunodeficiency Virus Type 1. J Biol Chem. 2001, 276: 5445-5451. 10.1074/jbc.M006892200.PubMed
- Bernstein KA, Gangloff S, Rothstein R: The RecQ DNA helicases in DNA repair. Annu Rev Genet. 2010, 44: 393-417. 10.1146/annurev-genet-102209-163602.PubMed CentralPubMed
- Laine JP, Opresko PL, Indig FE, Harrigan JA, von Kobbe C, Bohr VA: Werner protein stimulates topoisomerase I DNA relaxation activity. Cancer Res. 2003, 63: 7136-7146.PubMed
- Zhang S, Grosse F: Domain structure of human nuclear DNA helicase II (RNA helicase A). J Biol Chem. 1997, 272: 11487-11494. 10.1074/jbc.272.17.11487.PubMed
- Bolinger C, Sharma A, Singh D, Yu L, Boris-Lawrie K: RNA helicase A modulates translation of HIV-1 and infectivity of progeny virions. Nucleic Acids Res. 2010, 38: 1686-1696. 10.1093/nar/gkp1075.PubMed CentralPubMed
- Friedemann J, Grosse F, Zhang S: Nuclear DNA helicase II (RNA helicase A) interacts with Werner syndrome helicase and stimulates its exonuclease activity. J Biol Chem. 2005, 280: 31303-31313. 10.1074/jbc.M503882200.PubMed
- Chakraborty P, Grosse F: WRN helicase unwinds Okazaki fragment-like hybrids in a reaction stimulated by the human DHX9 helicase. Nucleic Acids Res. 2010, 38: 4722-4730. 10.1093/nar/gkq240.PubMed CentralPubMed
- Pollard VW, Malim MH: The HIV-1 Rev protein. Annu Rev Microbiol. 1998, 52: 491-532. 10.1146/annurev.micro.52.1.491.PubMed
- Snay-Hodge CA, Colot HV, Goldstein AL, Cole CN: Dbp5p/Rat8p is a yeast nuclear pore-associated DEAD-box protein essential for RNA export. EMBO J. 1998, 17: 2663-2676. 10.1093/emboj/17.9.2663.PubMed CentralPubMed
- Kula A, Guerra J, Knezevich A, Kleva D, Myers MP, Marcello A: Characterization of the HIV-1 RNA associated proteome identifies Matrin 3 as a nuclear cofactor of Rev function. Retrovirology. 2011, 8: 60-10.1186/1742-4690-8-60.PubMed CentralPubMed
- Yedavalli VS, Jeang KT: Matrin 3 is a co-factor for HIV-1 Rev in regulating post-transcriptional viral gene expression. Retrovirology. 2011, 8: 61-10.1186/1742-4690-8-61.PubMed CentralPubMed
- Lai MC, Lee YH, Tarn WY: The DEAD-box RNA helicase DDX3 associates with export messenger ribonucleoproteins as well as tip-associated protein and participates in translational control. Mol Biol Cell. 2008, 19: 3847-3858. 10.1091/mbc.E07-12-1264.PubMed CentralPubMed
- Lee CS, Dias AP, Jedrychowski M, Patel AH, Hsu JL, Reed R: Human DDX3 functions in translation and interacts with the translation initiation factor eIF3. Nucleic Acids Res. 2008, 36: 4708-4718. 10.1093/nar/gkn454.PubMed CentralPubMed
- Tarn WY, Chang TH: The current understanding of Ded1p/DDX3 homologs from yeast to human. RNA Biol. 2009, 6: 17-20. 10.4161/rna.6.1.7440.PubMed
- Hilliker A, Gao Z, Jankowsky E, Parker R: The DEAD-box protein Ded1 modulates translation by the formation and resolution of an eIF4F-mRNA complex. Mol Cell. 2011, 43: 962-972. 10.1016/j.molcel.2011.08.008.PubMed CentralPubMed
- Ishaq M, Hu J, Wu X, Fu Q, Yang Y, Liu Q, Guo D: Knockdown of cellular RNA helicase DDX3 by short hairpin RNAs suppresses HIV-1 viral replication without inducing apoptosis. Mol Biotechnol. 2008, 39: 231-238. 10.1007/s12033-008-9040-0.PubMed
- Garbelli A, Beermann S, Di Cicco G, Dietrich U, Maga G: A motif unique to the human DEAD-box protein DDX3 is important for nucleic acid binding, ATP hydrolysis, RNA/DNA unwinding and HIV-1 replication. PLoS One. 2011, 6: e19810-10.1371/journal.pone.0019810.PubMed CentralPubMed
- Fang J, Kubota S, Yang B, Zhou N, Zhang H, Godbout R, Pomerantz RJ: A DEAD box protein facilitates HIV-1 replication as a cellular co-factor of Rev. Virology. 2004, 330: 471-480. 10.1016/j.virol.2004.09.039.PubMed
- Edgcomb SP, Carmel AB, Naji S, Ambrus-Aikelin G, Reyes JR, Saphire AC, Gerace L, Williamson JR: DDX1 Is an RNA-Dependent ATPase Involved in HIV-1 Rev Function and Virus Replication. J Mol Biol. 2012, 415: 61-74. 10.1016/j.jmb.2011.10.032.PubMed CentralPubMed
- Robertson-Anderson RM, Wang J, Edgcomb SP, Carmel AB, Williamson JR, Millar DP: Single-molecule studies reveal that DEAD box protein DDX1 promotes oligomerization of HIV-1 Rev on the Rev response element. J Mol Biol. 2011, 410: 959-971. 10.1016/j.jmb.2011.04.026.PubMed CentralPubMed
- Malim MH, Cullen BR: HIV-1 structural gene expression requires the binding of multiple Rev monomers to the viral RRE: implications for HIV-1 latency. Cell. 1991, 65: 241-248. 10.1016/0092-8674(91)90158-U.PubMed
- Fang J, Acheampong E, Dave R, Wang F, Mukhtar M, Pomerantz RJ: The RNA helicase DDX1 is involved in restricted HIV-1 Rev function in human astrocytes. Virology. 2005, 336: 299-307. 10.1016/j.virol.2005.03.017.PubMed
- Naji S, Ambrus G, Cimermancic P, Reyes JR, Johnson JR, Filbrandt R, Huber MD, Vesely P, Krogan NJ, Yates JR, et al: Host cell interactome of HIV-1 Rev includes RNA helicases involved in multiple facets of virus production. Mol Cell Proteomics. 2012, 11 (4): M111.015313-10.1074/mcp.M111.015313.PubMed CentralPubMed
- Jager S, Cimermancic P, Gulbahce N, Johnson JR, McGovern KE, Clarke SC, Shales M, Mercenne G, Pache L, Li K, et al: Global landscape of HIV-human protein complexes. Nature. 2011, 481: 365-370.PubMed CentralPubMed
- Sundquist WI, Krausslich HG: HIV-1 Assembly, Budding, and Maturation. Cold Spring Harb Perspect Med. 2012, 2: a006924-PubMed CentralPubMed
- Chertova E, Chertov O, Coren LV, Roser JD, Trubey CM, Bess JW, Sowder RC, Barsov E, Hood BL, Fisher RJ, et al: Proteomic and biochemical analysis of purified human immunodeficiency virus type 1 produced from infected monocyte-derived macrophages. J Virol. 2006, 80: 9039-9052. 10.1128/JVI.01013-06.PubMed CentralPubMed
- Santos S, Obukhov Y, Nekhai S, Bukrinsky M, Iordanskiy S: Virus-producing cells determine the host protein profiles of HIV-1 virion cores. Retrovirology. 2012, 9: 65-10.1186/1742-4690-9-65.PubMed CentralPubMed
- Roy BB, Hu J, Guo X, Russell RS, Guo F, Kleiman L, Liang C: Association of RNA helicase a with human immunodeficiency virus type 1 particles. J Biol Chem. 2006, 281: 12625-12635. 10.1074/jbc.M510596200.PubMed
- Wang X, Han Y, Dang Y, Fu W, Zhou T, Ptak RG, Zheng YH: Moloney leukemia virus 10 (MOV10) protein inhibits retrovirus replication. J Biol Chem. 2010, 285: 14346-14355. 10.1074/jbc.M110.109314.PubMed CentralPubMed
- Furtak V, Mulky A, Rawlings SA, Kozhaya L, Lee K, Kewalramani VN, Unutmaz D: Perturbation of the P-body component Mov10 inhibits HIV-1 infectivity. PLoS One. 2010, 5: e9081-10.1371/journal.pone.0009081.PubMed CentralPubMed
- Burdick R, Smith JL, Chaipan C, Friew Y, Chen J, Venkatachari NJ, Delviks-Frankenberry KA, Hu WS, Pathak VK: P body-associated protein Mov10 inhibits HIV-1 replication at multiple stages. J Virol. 2010, 84: 10241-10253. 10.1128/JVI.00585-10.PubMed CentralPubMed
- Xing L, Liang C, Kleiman L: Coordinate roles of Gag and RNA helicase A in promoting the annealing of formula to HIV-1 RNA. J Virol. 2011, 85: 1847-1860. 10.1128/JVI.02010-10.PubMed CentralPubMed
- Abudu A, Wang X, Dang Y, Zhou T, Xiang SH, Zheng YH: Identification of molecular determinants from moloney Leukemia virus 10 homolog (MOV10) protein for virion packaging and anti-human immunodeficiency virus type 1 (HIV-1) activity. J Biol Chem. 2012, 287: 1220-1228. 10.1074/jbc.M111.309831.PubMed CentralPubMed
- Arjan-Odedra S, Swanson CM, Sherer NM, Wolinsky SM, Malim MH: Endogenous MOV10 inhibits the retrotransposition of endogenous retroelements but not the replication of exogenous retroviruses. Retrovirology. 2012, 9: 53-10.1186/1742-4690-9-53.PubMed CentralPubMed
- Lu C, Luo Z, Jaeger S, Krogan N, Peterlin BM: MOV10 inhibits IAP reverse transcription and retrotransposition. J Virol. 2012, 86: 10517-10523. 10.1128/JVI.00868-12.PubMed CentralPubMed
- Meister G, Landthaler M, Peters L, Chen PY, Urlaub H, Luhrmann R, Tuschl T: Identification of novel argonaute-associated proteins. Curr Biol. 2005, 15: 2149-2155. 10.1016/j.cub.2005.10.048.PubMed
- Banerjee S, Neveu P, Kosik KS: A coordinated local translational control point at the synapse involving relief from silencing and MOV10 degradation. Neuron. 2009, 64: 871-884. 10.1016/j.neuron.2009.11.023.PubMed
- Bouttier M, Saumet A, Peter M, Courgnaud V, Schmidt U, Cazevieille C, Bertrand E, Lecellier CH: Retroviral GAG proteins recruit AGO2 on viral RNAs without affecting RNA accumulation and translation. Nucleic Acids Res. 2012, 40: 775-786. 10.1093/nar/gkr762.PubMed CentralPubMed
- Bolinger C, Boris-Lawrie K: Mechanisms employed by retroviruses to exploit host factors for translational control of a complicated proteome. Retrovirology. 2009, 6: 8-10.1186/1742-4690-6-8.PubMed CentralPubMed
- Bolinger C, Yilmaz A, Hartman TR, Kovacic MB, Fernandez S, Ye J, Forget M, Green PL, Boris-Lawrie K: RNA helicase A interacts with divergent lymphotropic retroviruses and promotes translation of human T-cell leukemia virus type 1. Nucleic Acids Res. 2007, 35: 2629-2642. 10.1093/nar/gkm124.PubMed CentralPubMed
- Hartman TR, Qian S, Bolinger C, Fernandez S, Schoenberg DR, Boris-Lawrie K: RNA helicase A is necessary for translation of selected messenger RNAs. Nat Struct Mol Biol. 2006, 13: 509-516. 10.1038/nsmb1092.PubMed
- Pisareva VP, Pisarev AV, Komar AA, Hellen CU, Pestova TV: Translation initiation on mammalian mRNAs with structured 5′UTRs requires DExH-box protein DHX29. Cell. 2008, 135: 1237-1250. 10.1016/j.cell.2008.10.037.PubMed CentralPubMed
- Parsyan A, Shahbazian D, Martineau Y, Petroulakis E, Alain T, Larsson O, Mathonnet G, Tettweiler G, Hellen CU, Pestova TV, et al: The helicase protein DHX29 promotes translation initiation, cell proliferation, and tumorigenesis. Proc Natl Acad Sci U S A. 2009, 106: 22217-22222. 10.1073/pnas.0909773106.PubMed CentralPubMed
- Buck CB, Shen X, Egan MA, Pierson TC, Walker CM, Siliciano RF: The human immunodeficiency virus type 1 gag gene encodes an internal ribosome entry site. J Virol. 2001, 75: 181-191. 10.1128/JVI.75.1.181-191.2001.PubMed CentralPubMed
- Brasey A, Lopez-Lastra M, Ohlmann T, Beerens N, Berkhout B, Darlix JL, Sonenberg N: The leader of human immunodeficiency virus type 1 genomic RNA harbors an internal ribosome entry segment that is active during the G2/M phase of the cell cycle. J Virol. 2003, 77: 3939-3949. 10.1128/JVI.77.7.3939-3949.2003.PubMed CentralPubMed
- Yedavalli VS, Jeang KT: Trimethylguanosine capping selectively promotes expression of Rev-dependent HIV-1 RNAs. Proc Natl Acad Sci U S A. 2010, 107: 14787-14792. 10.1073/pnas.1009490107.PubMed CentralPubMed
- Arrigo SJ, Chen IS: Rev is necessary for translation but not cytoplasmic accumulation of HIV-1 vif, vpr, and env/vpu 2 RNAs. Genes Dev. 1991, 5: 808-819. 10.1101/gad.5.5.808.PubMed
- Yedavalli VS, Jeang KT: Rev-ing up post-transcriptional HIV-1 RNA expression. RNA Biol. 2011, 8: 195-199. 10.4161/rna.8.2.14803.PubMed CentralPubMed
- Gendron K, Ferbeyre G, Heveker N, Brakier-Gingras L: The activity of the HIV-1 IRES is stimulated by oxidative stress and controlled by a negative regulatory element. Nucleic Acids Res. 2011, 39: 902-912. 10.1093/nar/gkq885.PubMed CentralPubMed
- Vallejos M, Deforges J, Plank TD, Letelier A, Ramdohr P, Abraham CG, Valiente-Echeverria F, Kieft JS, Sargueil B, Lopez-Lastra M: Activity of the human immunodeficiency virus type 1 cell cycle-dependent internal ribosomal entry site is modulated by IRES trans-acting factors. Nucleic Acids Res. 2011, 39: 6186-6200. 10.1093/nar/gkr189.PubMed CentralPubMed
- Nicholson P, Yepiskoposyan H, Metze S, Zamudio Orozco R, Kleinschmidt N, Muhlemann O: Nonsense-mediated mRNA decay in human cells: mechanistic insights, functions beyond quality control and the double-life of NMD factors. Cell Mol Life Sci. 2010, 67: 677-700. 10.1007/s00018-009-0177-1.PubMed
- Hogg JR, Goff SP: Upf1 senses 3′UTR length to potentiate mRNA decay. Cell. 2010, 143: 379-389. 10.1016/j.cell.2010.10.005.PubMed CentralPubMed
- Bhattacharya A, Czaplinski K, Trifillis P, He F, Jacobson A, Peltz SW: Characterization of the biochemical properties of the human Upf1 gene product that is involved in nonsense-mediated mRNA decay. RNA. 2000, 6: 1226-1235. 10.1017/S1355838200000546.PubMed CentralPubMed
- Withers JB, Beemon KL: Structural features in the Rous sarcoma virus RNA stability element are necessary for sensing the correct termination codon. Retrovirology. 2010, 7: 65-10.1186/1742-4690-7-65.PubMed CentralPubMed
- Ajamian L, Abrahamyan L, Milev M, Ivanov PV, Kulozik AE, Gehring NH, Mouland AJ: Unexpected roles for UPF1 in HIV-1 RNA metabolism and translation. RNA. 2008, 14: 914-927. 10.1261/rna.829208.PubMed CentralPubMed
- Zhu Y, Chen G, Lv F, Wang X, Ji X, Xu Y, Sun J, Wu L, Zheng YT, Gao G: Zinc-finger antiviral protein inhibits HIV-1 infection by selectively targeting multiply spliced viral mRNAs for degradation. Proc Natl Acad Sci U S A. 2011, 108: 15834-15839. 10.1073/pnas.1101676108.PubMed CentralPubMed
- Gao G, Guo X, Goff SP: Inhibition of retroviral RNA production by ZAP, a CCCH-type zinc finger protein. Science. 2002, 297: 1703-1706. 10.1126/science.1074276.PubMed
- Guo X, Carroll JW, Macdonald MR, Goff SP, Gao G: The zinc finger antiviral protein directly binds to specific viral mRNAs through the CCCH zinc finger motifs. J Virol. 2004, 78: 12781-12787. 10.1128/JVI.78.23.12781-12787.2004.PubMed CentralPubMed
- Wang X, Lv F, Gao G: Mutagenesis analysis of the zinc-finger antiviral protein. Retrovirology. 2010, 7: 19-10.1186/1742-4690-7-19.PubMed CentralPubMed
- Ye P, Liu S, Zhu Y, Chen G, Gao G: DEXH-Box protein DHX30 is required for optimal function of the zinc-finger antiviral protein. Protein Cell. 2010, 1: 956-964. 10.1007/s13238-010-0117-8.PubMed
- Chen G, Guo X, Lv F, Xu Y, Gao G: p72 DEAD box RNA helicase is required for optimal function of the zinc-finger antiviral protein. Proc Natl Acad Sci U S A. 2008, 105: 4352-4357. 10.1073/pnas.0712276105.PubMed CentralPubMed
- LaCava J, Houseley J, Saveanu C, Petfalski E, Thompson E, Jacquier A, Tollervey D: RNA degradation by the exosome is promoted by a nuclear polyadenylation complex. Cell. 2005, 121: 713-724. 10.1016/j.cell.2005.04.029.PubMed
- Jia H, Wang X, Liu F, Guenther UP, Srinivasan S, Anderson JT, Jankowsky E: The RNA helicase Mtr4p modulates polyadenylation in the TRAMP complex. Cell. 2011, 145: 890-901. 10.1016/j.cell.2011.05.010.PubMed CentralPubMed
- Russell RS, Liang C, Wainberg MA: Is HIV-1 RNA dimerization a prerequisite for packaging? Yes, no, probably?. Retrovirology. 2004, 1: 23-10.1186/1742-4690-1-23.PubMed CentralPubMed
- Lu K, Heng X, Summers MF: Structural determinants and mechanism of HIV-1 genome packaging. J Mol Biol. 2011, 410: 609-633. 10.1016/j.jmb.2011.04.029.PubMed CentralPubMed
- Paillart JC, Shehu-Xhilaga M, Marquet R, Mak J: Dimerization of retroviral RNA genomes: an inseparable pair. Nat Rev Microbiol. 2004, 2: 461-472. 10.1038/nrmicro903.PubMed
- Lever AM: HIV-1 RNA packaging. Adv Pharmacol. 2007, 55: 1-32.PubMed
- Lu K, Heng X, Garyu L, Monti S, Garcia EL, Kharytonchyk S, Dorjsuren B, Kulandaivel G, Jones S, Hiremath A, et al: NMR detection of structures in the HIV-1 5′-leader RNA that regulate genome packaging. Science. 2011, 334: 242-245. 10.1126/science.1210460.PubMed CentralPubMed
- Cockrell AS, van Praag H, Santistevan N, Ma H, Kafri T: The HIV-1 Rev/RRE system is required for HIV-1 5′ UTR cis elements to augment encapsidation of heterologous RNA into HIV-1 viral particles. Retrovirology. 2011, 8: 51-10.1186/1742-4690-8-51.PubMed CentralPubMed
- Rao VB, Feiss M: The bacteriophage DNA packaging motor. Annu Rev Genet. 2008, 42: 647-681. 10.1146/annurev.genet.42.110807.091545.PubMed
- Yu SF, Lujan P, Jackson DL, Emerman M, Linial ML: The DEAD-box RNA helicase DDX6 is required for efficient encapsidation of a retroviral genome. PLoS Pathog. 2011, 7: e1002303-10.1371/journal.ppat.1002303.PubMed CentralPubMed
- Reed JC, Molter B, Geary CD, McNevin J, McElrath J, Giri S, Klein KC, Lingappa JR: HIV-1 Gag co-opts a cellular complex containing DDX6, a helicase that facilitates capsid assembly. J Cell Biol. 2012, 198: 439-456. 10.1083/jcb.201111012.PubMed CentralPubMed
- Ma J, Rong L, Zhou Y, Roy BB, Lu J, Abrahamyan L, Mouland AJ, Pan Q, Liang C: The requirement of the DEAD-box protein DDX24 for the packaging of human immunodeficiency virus type 1 RNA. Virology. 2008, 375: 253-264. 10.1016/j.virol.2008.01.025.PubMed
- Zhou Y, Ma J, Bushan Roy B, Wu JY, Pan Q, Rong L, Liang C: The packaging of human immunodeficiency virus type 1 RNA is restricted by overexpression of an RNA helicase DHX30. Virology. 2008, 372: 97-106. 10.1016/j.virol.2007.10.027.PubMed
- Sloan RD, Kuhl BD, Donahue DA, Roland A, Bar-Magen T, Wainberg MA: Transcription of preintegrated HIV-1 cDNA modulates cell surface expression of major histocompatibility complex class I via Nef. J Virol. 2011, 85: 2828-2836. 10.1128/JVI.01854-10.PubMed CentralPubMed
- Li X, Krishnan L, Cherepanov P, Engelman A: Structural biology of retroviral DNA integration. Virology. 2011, 411: 194-205. 10.1016/j.virol.2010.12.008.PubMed CentralPubMed
- Raghavendra NK, Shkriabai N, Graham R, Hess S, Kvaratskhelia M, Wu L: Identification of host proteins associated with HIV-1 preintegration complexes isolated from infected CD4+ cells. Retrovirology. 2010, 7: 66-10.1186/1742-4690-7-66.PubMed CentralPubMed
- Studamire B, Goff SP: Host proteins interacting with the Moloney murine leukemia virus integrase: multiple transcriptional regulators and chromatin binding factors. Retrovirology. 2008, 5: 48-10.1186/1742-4690-5-48.PubMed CentralPubMed
- Jeanson L, Subra F, Vaganay S, Hervy M, Marangoni E, Bourhis J, Mouscadet JF: Effect of Ku80 depletion on the preintegrative steps of HIV-1 replication in human cells. Virology. 2002, 300: 100-108. 10.1006/viro.2002.1515.PubMed
- Espeseth AS, Fishel R, Hazuda D, Huang Q, Xu M, Yoder K, Zhou H: siRNA screening of a targeted library of DNA repair factors in HIV infection reveals a role for base excision repair in HIV integration. PLoS One. 2011, 6: e17612-10.1371/journal.pone.0017612.PubMed CentralPubMed
- Yoder KE, Espeseth A, Wang XH, Fang Q, Russo MT, Lloyd RS, Hazuda D, Sobol RW, Fishel R: The base excision repair pathway is required for efficient lentivirus integration. PLoS One. 2011, 6: e17862-10.1371/journal.pone.0017862.PubMed CentralPubMed
- Yoder K, Sarasin A, Kraemer K, McIlhatton M, Bushman F, Fishel R: The DNA repair genes XPB and XPD defend cells from retroviral infection. Proc Natl Acad Sci U S A. 2006, 103: 4622-4627. 10.1073/pnas.0509828103.PubMed CentralPubMed
- Yoder KE, Roddick W, Hoellerbauer P, Fishel R: XPB mediated retroviral cDNA degradation coincides with entry to the nucleus. Virology. 2011, 410: 291-298. 10.1016/j.virol.2010.11.016.PubMed CentralPubMed
- Kawasaki T, Kawai T, Akira S: Recognition of nucleic acids by pattern-recognition receptors and its relevance in autoimmunity. Immunol Rev. 2011, 243: 61-73. 10.1111/j.1600-065X.2011.01048.x.PubMed
- Solis M, Nakhaei P, Jalalirad M, Lacoste J, Douville R, Arguello M, Zhao T, Laughrea M, Wainberg MA, Hiscott J: RIG-I-mediated antiviral signaling is inhibited in HIV-1 infection by a protease-mediated sequestration of RIG-I. J Virol. 2011, 85: 1224-1236. 10.1128/JVI.01635-10.PubMed CentralPubMed
- Brass AL, Dykxhoorn DM, Benita Y, Yan N, Engelman A, Xavier RJ, Lieberman J, Elledge SJ: Identification of host proteins required for HIV infection through a functional genomics screen. Science. 2008, 319: 921-926. 10.1126/science.1152725.PubMed
- Genovesio A, Kwon YJ, Windisch MP, Kim NY, Choi SY, Kim HC, Jung S, Mammano F, Perrin V, Boese AS, et al: Automated genome-wide visual profiling of cellular proteins involved in HIV infection. J Biomol Screen. 2011, 16: 945-958. 10.1177/1087057111415521.PubMed
- Zhou H, Xu M, Huang Q, Gates AT, Zhang XD, Castle JC, Stec E, Ferrer M, Strulovici B, Hazuda DJ, Espeseth AS: Genome-scale RNAi screen for host factors required for HIV replication. Cell Host Microbe. 2008, 4: 495-504. 10.1016/j.chom.2008.10.004.PubMed
- Krishnan V, Zeichner SL: Host cell gene expression during human immunodeficiency virus type 1 latency and reactivation and effects of targeting genes that are differentially expressed in viral latency. J Virol. 2004, 78: 9458-9473. 10.1128/JVI.78.17.9458-9473.2004.PubMed CentralPubMed
- Krishnan V, Zeichner SL: Alterations in the expression of DEAD-box and other RNA binding proteins during HIV-1 replication. Retrovirology. 2004, 1: 42-10.1186/1742-4690-1-42.PubMed CentralPubMed
- Kwong AD, Rao BG, Jeang KT: Viral and cellular RNA helicases as antiviral targets. Nat Rev Drug Discov. 2005, 4: 845-853. 10.1038/nrd1853.PubMed
- Chen CY, Liu X, Boris-Lawrie K, Sharma A, Jeang KT: Cellular RNA helicases and HIV-1: Insights from genome-wide, proteomic, and molecular studies. Virus Res. 2012, : -Epub ahead of print
- Ajamian L, Mouland AJ: Implications of RNA helicases in HIV-1replication: possible roles in latency. Curr HIV Res. 2011, 9: 588-594. 10.2174/157016211798998835.PubMed
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.